Showing results (101-110 of 148) with videos related to
Sort By:
Pageof 15
Clinical Pharmacology and Therapeutics|July 1, 1980
Pyridostigmine kinetics with and without renal functionR Cronnelly, D R Stanski, R D Miller, et al.European Journal of Clinical Pharmacology|August 23, 2000
Nasal mucosal versus gastrointestinal absorption of nasally administered cocaineK Fattinger, N L Benowitz, R T Jones, et al.The Journal of Pharmacology and Experimental Therapeutics|March 23, 1999
Down-regulation models and modeling of testosterone production induced by recombinant human choriogonadotropinJ M Gries, A Munafo, H C Porchet, et al.Experimental Hematology|May 1, 1992
Effects of interleukin 3 and interleukin 6 on platelet recovery in mice treated with 5-fluorouracilP A Carrington, R J Hill, J Levin, et al.Journal of Receptor Research|January 1, 1986
Allosteric inhibition as a model to explain flatter displacement curves in binding experiments: application to "heterogeneous" serotonin receptorsM Gobbi, D Barone, G Dagnino, et al.Annals of Internal Medicine|May 1, 1975
Improved computer-assisted digoxin therapy. A method using feedback of measured serum digoxin concentrationsL B Sheiner, H Halkin, C Peck, et al.Clinical Pharmacology and Therapeutics|March 1, 1995
A population model for the leukopenic effect of etoposideM O Karlsson, R E Port, M J Ratain, et al.Cardiovascular Research|February 1, 1982
Clearance of serum creatine kinase activityC J Carlson, W Meister, B Emilson, et al.The Journal of Clinical Investigation|November 1, 1987
Apparent tolerance to the acute effect of nicotine results in part from distribution kineticsH C Porchet, N L Benowitz, L B Sheiner, et al.Life Sciences|January 1, 1988
D-optimal design applied to binding saturation curves of an enkephalin analog in rat brainD Verotta, P Petrillo, A La Regina, et al.Pageof 15